These data provide additional insights into the possible immune response that HIV-1 infection or viral Env-based immunization could elicit and help in the design of candidate vaccine immunogens that elicit potent neutralizers of early transmitted virus. The gene discussed is ERVW-1; the disease is HIV-1 infection.